Induction of immune tolerance to RBC, platelet, and neutrophil antigens and IgA

Medical Hypotheses
K G Badami

Abstract

Antibodies to red blood cell (RBC), platelet, and neutrophil antigens, and IgA may cause serious clinical problems. With a few exceptions, preventing these conditions is a matter of limiting exposure to the foreign antigen while treatment consists of managing the consequences. Might immune tolerance induction (ITI) be possible and beneficial in these situations? Neonatal exposure to antigens is known to induce central tolerance. However central tolerance may not be absolute. Factors that determine whether an antibody will be produced in response to an antigen are not well understood but include the appropriate expression of major histocompatibility complex-class II and/or co-stimulatory molecules on dendritic cells, the presence or absence of adjuvants and whether or not the antigen is presented together with agonists for the toll-like receptor. Modifying these may prevent alloimmunization. Peripheral tolerance, in sensitized individuals, as routinely used in patients with allergic/anaphylactic reactions, those with haemophilia A or B with inhibitors and acquired haemophilia, may also be possible. Briefly, monitored, graded, increasing exposure to the antigen of interest with or without additional immunosuppression is used. Nei...Continue Reading

References

May 11, 2000·Blood Reviews·S J Urbaniak, M A Greiss
Apr 16, 2002·Science·Polly Matzinger
Jul 3, 2002·Nature Reviews. Immunology·Stephen M Anderton, David C Wraith
Apr 22, 2004·Journal of Thrombosis and Haemostasis : JTH·S MadoiwaY Sakata
May 19, 2004·The Journal of Experimental Medicine·Irina Apostolou, Harald von Boehmer
Jun 11, 2005·Mayo Clinic Proceedings·Ognjen Gajic, S Breanndan Moore
Nov 18, 2005·Nature·Chandrashekhar Pasare, Ruslan Medzhitov
May 31, 2008·British Journal of Haematology·Eldad Hod, Joseph Schwartz
May 31, 2008·Cell·Shimon SakaguchiMasahiro Ono
Dec 2, 2008·Transfusion·Christopher A Tormey, Gary Stack
Jan 1, 2008·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Erwin Strobel
Feb 7, 2013·British Journal of Haematology·Julie A PetersonRichard H Aster
Sep 7, 2013·Thrombosis and Haemostasis·Massimo Franchini, Pier Mannuccio Mannucci

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

B cell Tolerance

B cell tolerance is maintained through mechanisms that can reversibly or irreversibly silence autoreactive B lymphocytes. Here is the latest research.

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.